Ripple Mehta

Cell therapy, Biologics, Biosimilars, Director- BD and Strategic Alliance

Role: Director - Bd and Strategic Alliance at Kemwell Biopharma
Location: San Francisco, CA, US
LinkedIn followers: 500 followers

Sales & Business DevelopmentView LinkedIn profile

Experience

Director - Bd and Strategic Alliance
Kemwell Biopharma
Aug 2023 — Present · CA, US

Education

L.M.College of Pharmacy
B.Pharm, MBA, Pharmaceuticals, International Marketing
1998 — 2001

Skills

Mergers
Competitive Analysis
Pharmaceutical Industry
Lifesciences
Market Research
Biotechnology
Oncology
Valuation
Equity Research
Equity Valuation
Financial Modeling

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@kemwellbiopharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Kemwell Biopharma

Biotechnology · 540 employees · Founded 1980 · Bangalore, Karnataka, India

Kemwell is a contract biologics development and CMO company providing services to global biopharmaceutical organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products’ development and manufacturing. sq. m. Kemwell facility consists of a cGMP drug substance manufacturing area with over 4500L bioreactor capacity, sterile fill and finish areas for cGMP drug product manufacturing and process development laboratories to support production of protein therapeutics from mammalian-cell culture – monoclonal antibodies, bi-specific antibodies, fusion proteins, etc. Kemwell is capable of supporting novel, bio-better and biosimilar programs’ preclinical development, clinical development, cGMP clinical manufacturing and cGMP commercial manufacturing. Kemwell, having established in 1980, had long term associations with pharma majors such as Bayer, GlaxoSmithKline, Merck KGaA, Novartis, Pfizer and others for small molecule contract mfg. and R&D. In 2016, Kemwell divested its small-molecule division to focus on biologics, leveraging its vast and rich experience. Kemwell is now a 100% biologics CDMO.

kemwellbiopharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Director - Bd and Strategic Alliance

Education

L.M.College of Pharmacy

Skills

Find verified contacts for anyone on LinkedIn